Find valuable ACTEMRA® (tocilizumab) information, including an ACTEMRA® dosing calculator, RA patient brochure, ACTEMRA® prescription guide and the. Tocilizumab (Actemra) is a biologic reference guide with prescribing information, dosage, medication administration, and possible side effects. Each vial contains 80 mg of tocilizumab* in 4 ml (20 mg/ml). . Dose interruptions of tocilizumab for the following laboratory abnormalities are recommended in.
|Published (Last):||5 May 2014|
|PDF File Size:||9.34 Mb|
|ePub File Size:||6.43 Mb|
|Price:||Free* [*Free Regsitration Required]|
Sign Up It’s Free!
Forms & Documents | Genentech Rheumatology Access Solutions
Peak plasma time in GCA patients: Before prescribing or administering any drug contained in this biologic reference guide, health professionals should read the manufacturer’s complete prescribing information in order to be informed of the various clinical considerations to be actemra prescribing information into account. Most commonly, these are “non-preferred” brand drugs. Managing Actemra prescribing information Reactions Acute infusion reaction can occur during the administration of tocilizumab or within 24 hours of infusion.
For full Safety Informationplease see below.
Please select a treatment to continue
Tocilizumab actemra prescribing information not been studied in combination actemra prescribing information biological DMARDs eg, TNF antagonists, IL-1R antagonists, anti-CD20 monoclonal antibodies, selective costimulation modulators and its use should be avoided in combination with these agents because of increased immunosuppression and risk of infection. Reporting side effects Tell your healthcare provider right away if you are experiencing any side effects.
Resume mg preescribing every other week and increase frequency to every week as clinically appropriate. Hypersensitivity reactions including anaphylaxis and death. Platelets are blood cells that help with clotting, which stops bleeding increase in liver function test levels increase in blood cholesterol levels. Your healthcare provider should do blood tests to check your cholesterol levels 4 to 8 informatio after you peescribing receiving ACTEMRA, infofmation then every 6 months after that You should not receive ACTEMRA if your neutrophil and actemra prescribing information counts are too low or your liver function test levels are too high.
Tocilizumab should not be given to patients who have experienced anaphylaxis or other severe hypersensitivity and not re-challenged. Fever Stomach-area pain that does actemra prescribing information go away Change in your bowel habits.
Share Email Print Feedback Close.
FDA Internet Application Site (Accessdata) Error
Share cases and questions with Physicians on Medscape consult. Genentech does not recommend and does not endorse the content on any third-party websites.
Do not dilute vials until after successfully obtaining intravenous actemra prescribing information. Do you need help?
Some people have died from these infections. The majority resolved without any treatment and none necessitated drug discontinuation.
Your email has been sent! If the answer is yes to any of these questions, notify the ordering provider before initiating the infusion therapy. Print with Office Info. Serious allergic reactions Serious allergic reactions, actemra prescribing information death, can happen infirmation ACTEMRA infusions or injections, even if they did actemra prescribing information occur with an earlier infusion or injection.
Contact immediately, as well as your healthcare provider or nurse, if you experience any of these reactions:. Zoledronic Acid Reclast Medication Guide: Resume at mg every other week and increase frequency to every week as clinically appropriate.
Dose interruptions are recommended for liver enzyme abnormalities, low neutrophil counts, and low platelet counts in patients with PJIA and SJIA at levels similar to what is outlined for adults with RA. If the patient reports mild reactions such as flushing, chills, etc.
Gastrointestinal Perforations Events of gastrointestinal GI perforation have been reported in clinical trials, primarily as complications actemra prescribing information diverticulitis in RA patients. Pegloticase Krystexxa Medication Guide: The above information is provided for general informational and educational purposes only.
Serious allergic reactions, acyemra death, can happen with ACTEMRA infusions or injections, even if actemra prescribing information did not occur with an earlier infusion or injection. Forms and Documents Here you can download the form you need to enroll in Genentech Rheumatology Access Solutions and other important information. Bacterial, actemrq and other infections due to opportunistic pathogens.
The infusion should be administered over 60 minutes, and must be administered with an infusion set. The rate of serious infections was 9.
Medication Guide: Tocilizumab (Actemra)
Laboratory monitoring — recommended due to potential consequences of treatment-related changes in neutrophils, platelets, lipids and liver specific enzymes. Thanks for sharing this page. No dosage adjustment required Moderate-to-severe: Increased frequency and magnitude actemra prescribing information these elevations was observed when potentially hepatotoxic precribing e. Patients must tell their doctor if they have these or any aftemra side effect that bothers them or does not go away:.
Your cholesterol levels should be checked 4 to 8 weeks actemra prescribing information the start of your treatment, and then every 6 months after that.
Quantity Limits Drugs that have quantity limits associated with each prescription. Actemra prescribing information are white blood cells that help the body fight infection low platelet count.
By providing prrescribing information, ACR actemra prescribing information not endorsing or recommending any of the listed companies or any of their drugs or other products. By clicking actemra prescribing information, you acknowledge that you have permission to email the recipient with this information.
ACTEMRA is indicated for the treatment of active systemic juvenile idiopathic arthritis in patients 2 years of age and older. Pre-Infusion Checklist Confirm the following: Half-life in GCA patients: SC Dosing Patients weighing less than kg: Contact immediately, as well as your healthcare provider or nurse, if you experience actema of these reactions: Patients must tell their doctor if infomration have these or any other side effect that bothers them or does not go away: